Company profile
InflaRx company profile
InflaRx develops new therapeutics in the field of acute and chronic inflammation and consists of a team of internationally recognized researchers and clinicians who have dedicated their careers to translate discoveries and expertise into new therapeutic concepts for clinical application. In April 2018, InflaRx conducted a USD 117 million total gross proceeds follow-on transaction on the US Nasdaq global select market comprised of a primary component of USD 63 million investment into InflaRx as well as a secondary component of USD 54 million to existing first-day shareholders of InflaRx. InflaRx was founded in December 2017 and is headquartered in Jena,..... For more information, log in to dureach.com to view the full company profile.
Business identity
- Website
- https://www.inflarx.de/
- Contact email
- [email protected]
- Phone number
- +49 (0)3641 508 180
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 00051-00100 employees
- Revenue range
- $0+
- Founded
- 2007-12-01
Headquarters
- Headquarters
- Kleinniedesheim, Rheinland-Pfalz, Germany
- Postal code
- 07743
- Country code
- DE
- Continent
- Europe